Visit HubMedEd to explore all our resources
2 mg Weeks 14 Introductory dose to establish tolerability
Cluster 1 included allergies, anxiety, depression, chronic obstructive pulmonary disease, fatigue, fever, hypertension, indigestion, insomnia, gastroesophageal reflux disease, hives, swelling, restlessness, and seizures
You may also benefit from making sure you hit your daily targets for protein and water intake
In the trials, different dosage levels are being tested to see how they impact weight loss and other health markers
Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA Compounded Semaglutide (GLP-1) Injections A once-weekly GLP-1 injection designed to help reduce appetite, improve metabolic health, and support sustainable weight loss under licensed medical supervision